UTI AMC

Why is UTI Asset Management Company Ltd falling/rising?

As of 07-Aug, UTI Asset Management Company Ltd's stock price is at Rs 896.75, down 0.34%, and has significantly underperformed the Sensex with a year-to-date decline of 20.57%. The stock is near its 52-week low, trading below key moving averages, and experiencing decreased investor interest, despite a high dividend yield and strong fundamentals.

As of 07-Aug, UTI Asset Management Company Ltd's stock price is falling, currently at Rs 896.75, reflecting a decrease of Rs 3.1 or 0.34%. The stock has underperformed significantly compared to the benchmark Sensex over various periods, with a year-to-date decline of 20.57% against the Sensex's 7.89% drop, and a one-year decline of 33.15% compared to the Sensex's 2.63% decline. <BR><BR>The stock is also trading close to its 52-week low, just 2.34% away from Rs 877. Additionally, it is trading below all key moving averages, indicating a bearish trend. Investor participation has decreased markedly, with delivery volume dropping by 68.54% compared to the five-day average, suggesting a lack of interest from investors. <BR><BR>Despite some positive factors, such as a high dividend yield of 4.47% and strong long-term fundamentals, the recent performance metrics indicate a challenging environment for the stock. The company's profits have fallen by 23.6% over the past year, contributing to the negative sentiment surrounding the stock. Overall, these factors collectively explain the current decline in UTI Asset Management Company Ltd's stock price.

Which are the latest news on UTI AMC?

Are UTI Asset Management Company Ltd latest results good or bad?

UTI Asset Management Company Ltd's latest results for Q1 FY27 show a strong recovery with a net profit of ₹293.86 crore, up 540.50% quarter-on-quarter. However, concerns about its return on equity and underperformance compared to peers suggest cautious market sentiment despite the positive operational metrics.

UTI Asset Management Company Ltd's latest results for Q1 FY27 indicate a strong recovery following a challenging previous quarter. The company reported a net profit of ₹293.86 crore, which is a significant turnaround from a loss of ₹66.71 crore in Q4 FY26, marking a remarkable 540.50% increase quarter-on-quarter. Year-on-year, the net profit also shows a healthy growth of 24.07%.<BR><BR>Revenue for the quarter reached ₹583.51 crore, up 49.51% from the previous quarter and 6.70% year-on-year. The operating margin has improved to 65.56%, which is a record high for the company, reflecting effective cost management and operational efficiency.<BR><BR>However, despite these positive results, there are concerns regarding the company's return on equity (ROE), which stands at 10.84%, below the average for the sector. Additionally, UTI AMC has underperformed compared to its peers, with a significant decline in stock price over the past year.<BR><BR>In summary, while the latest results show strong operational metrics and a recovery from previous losses, the overall market sentiment remains cautious due to concerns about long-term growth and capital efficiency.

Should I buy, sell or hold UTI Asset Management Company Ltd?

What does UTI AMC do?

UTI Asset Management Company Ltd manages private equity, venture funds, mutual funds, and portfolio management services for individual and institutional investors. As of March 2026, it reported net sales of 390 Cr and a net profit of -67 Cr, with a market cap of INR 11,966 Cr.

Overview:<BR>UTI Asset Management Company Ltd operates in the Capital Markets industry, focusing on managing Private Equity and Venture Funds, mutual funds, portfolio management services, and retirement solutions for both individual and institutional investors.<BR><BR>History:<BR>The company was incorporated on November 14, 2002, and later converted to a Public Limited company, officially changing its name to UTI Asset Management Company Limited on November 14, 2007. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 390 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -67 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 11,966 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 24.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 5.14% <BR>Debt-Equity: 0.03 <BR>Return on Equity: 10.84% <BR>Price to Book: 2.65 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

How big is UTI AMC?

As of 10th June, UTI Asset Management Company Ltd has a market capitalization of 11,966.00 Cr, with Net Sales of 1,872.85 Cr and a Net Profit of 404.12 Cr reported in the latest four quarters.

As of 10th June, UTI Asset Management Company Ltd has a market capitalization of 11,966.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, UTI AMC reported Net Sales of 1,872.85 Cr and a Net Profit of 404.12 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 4,599.13 Cr and Total Assets of 5,658.41 Cr.

Who are in the management team of UTI AMC?

The management team of UTI AMC includes key members such as Imtaiyazur Rahman (Managing Director), D K Mehrotra (Chairman & Independent Director), and several independent directors. They oversee the company's operations and strategic direction.

The management team of UTI AMC includes the following individuals:<BR><BR>1. **Imtaiyazur Rahman** - Managing Director<BR>2. **Flemming Madsen** - Director<BR>3. **Narasimhan Seshadri** - Independent Director<BR>4. **Deepak Kumar Chatterjee** - Independent Director<BR>5. **Dipali H Sheth** - Independent Director<BR>6. **Edward Cage Bernard** - Director<BR>7. **Jayashree Vaidhyanthan** - Independent Director<BR>8. **Rajeev Kakar** - Independent Director<BR>9. **D K Mehrotra** - Chairman & Independent Director<BR>10. **Arvind Bhagwan Das Patkar** - Company Secretary & Compliance Officer<BR>11. **Kiran Kumar Tarania** - Nominee<BR>12. **Srivatsa Desikamani** - Nominee<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

Who are the peers of the UTI AMC?

UTI AMC's peers include CRISIL, Cams Services, NSDL, KFin Technologies, Prudent Corp, IIFL Capital, Indian Energy Exchange, ICRA, and CDSL. In terms of management risk, UTI AMC and ICRA are rated as good, while its 1-year return of -28.19% is better than Indian Energy Exchange's -38.79% but worse than Prudent Corp's -5.25%.

Peers: The peers of UTI AMC are CRISIL, Cams Services, N S D L, KFin Technolog., Prudent Corp, IIFL Capital, Indian Energy Ex, ICRA, and C D S L.<BR><BR>Quality Snapshot: Excellent management risk is observed at CRISIL, Cams Services, Prudent Corp, Indian Energy Ex, and C D S L, while Average management risk is found at N S D L and IIFL Capital. Good management risk is noted at UTI AMC and ICRA, while KFin Technolog. has a rating of Excellent for Growth, alongside Prudent Corp, while UTI AMC, N S D L, and Indian Energy Ex have Below Average growth, and the rest have ratings of Good or Excellent for Growth. All peers have Excellent capital structure except for UTI AMC, which has a rating of Excellent.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Prudent Corp at -5.25%, while the peer with the lowest is Indian Energy Ex at -38.79%. UTI AMC's 1-year return of -28.19% is better than Indian Energy Ex but worse than Prudent Corp. Additionally, KFin Technolog., Indian Energy Ex, and ICRA have negative six-month returns.

Is UTI AMC technically bullish or bearish?

As of November 19, 2025, the technical trend is mildly bearish, indicated by bearish signals from MACD, Bollinger Bands, KST, and OBV across weekly and monthly time frames, despite a mildly bullish daily moving average.

As of 19 November 2025, the technical trend has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by several key indicators. The MACD is mildly bearish on both the weekly and monthly time frames, while Bollinger Bands also indicate a bearish trend on both time frames. The KST and OBV are both mildly bearish weekly and monthly as well. Although the daily moving averages show a mildly bullish signal, the overall sentiment remains bearish due to the prevailing trends in the longer time frames. The stock has underperformed compared to the Sensex over the past month and year, further supporting the bearish outlook.

How has been the historical performance of UTI AMC?

UTI AMC has shown consistent growth in net sales and profits, with net sales rising from 1,266.86 Cr in March 2023 to 1,851.09 Cr in March 2025, and operating profit increasing to 1,110.42 Cr. However, earnings per share decreased slightly from 60.17 in March 2024 to 57.16 in March 2025, despite overall profit growth.

Answer:<BR>The historical performance of UTI AMC shows a consistent growth trend in net sales and profit over the years, with net sales reaching 1,851.09 Cr in March 2025, up from 1,736.96 Cr in March 2024 and significantly higher than 1,266.86 Cr in March 2023. Operating profit (PBDIT) also increased to 1,110.42 Cr in March 2025 from 1,040.37 Cr in March 2024, indicating improved operational efficiency. Profit before tax rose to 1,052.17 Cr in March 2025, compared to 986.84 Cr in the previous year, while profit after tax was 812.96 Cr, slightly up from 802.03 Cr in March 2024. The company's earnings per share (EPS) decreased to 57.16 in March 2025 from 60.17 in March 2024, reflecting a slight decline in profitability per share despite the overall profit growth. <BR><BR>Breakdown:<BR>Over the years, UTI AMC has demonstrated a robust growth trajectory in its financial performance. From March 2020 to March 2025, net sales have increased from 854.03 Cr to 1,851.09 Cr, showcasing a strong upward trend. Operating profit has also seen a significant rise, moving from 348.31 Cr in March 2020 to 1,110.42 Cr in March 2025, indicating enhanced operational efficiency. Profit before tax has followed suit, climbing from 341.30 Cr in March 2020 to 1,052.17 Cr in March 2025. However, the profit after tax has shown a more modest increase, reaching 812.96 Cr in March 2025, up from 802.03 Cr in March 2024. The company's earnings per share peaked in March 2024 at 60.17 but fell to 57.16 in March 2025. Overall, UTI AMC's financial metrics reflect a solid performance with increasing revenues and profits, despite some fluctuations in profitability per share.

Is UTI AMC overvalued or undervalued?

As of October 23, 2025, UTI AMC's stock is considered attractive and undervalued with a PE ratio of 28.68, significantly lower than peers like Bajaj Finance, and despite a year-to-date return of -1.86%, it has outperformed the Sensex over the last three years with a return of 73.81%.

As of 23 October 2025, the valuation grade for UTI AMC has moved from fair to attractive, indicating a more favorable assessment of the company's stock. The company is currently considered undervalued. Key ratios include a PE ratio of 28.68, an EV to EBITDA of 13.80, and a Price to Book Value of 0.38, which suggest that the stock is trading at a discount relative to its intrinsic value.<BR><BR>In comparison with peers, UTI AMC's PE ratio of 28.68 is significantly lower than that of Bajaj Finance at 39.07, which is categorized as very expensive, while Life Insurance, rated very attractive, has a PE of 11.68. The company's recent performance has been mixed, with a year-to-date return of -1.86% compared to the Sensex's 8.21%, but over the last three years, UTI AMC has outperformed the Sensex with a return of 73.81% versus 42.57%.

Who are the top shareholders of the UTI AMC?

The top shareholders of UTI AMC include T. Rowe Price International Ltd with 22.79%, 23 mutual fund schemes holding 13.14%, and 178 foreign institutional investors with 7.85%. Individual investors account for 7.44%, with no pledged promoter holdings reported.

The top shareholders of UTI AMC include T. Rowe Price International Ltd, which holds a significant 22.79% of the shares. Additionally, the company has 23 mutual fund schemes collectively holding 13.14% and 178 foreign institutional investors (FIIs) with a combined holding of 7.85%. Individual investors also account for 7.44% of the shareholding. Notably, there are no pledged promoter holdings and no specific promoter with the highest holding mentioned.

When is the next results date for UTI AMC?

No Upcoming Board Meetings

Has UTI AMC declared dividend?

Yes, UTI Asset Management Company Ltd has declared a 240% dividend, amounting to ₹24 per share, with an ex-date of July 18, 2024. The dividend yield is 3.96%, and total returns have shown strong performance over longer periods despite a recent decline.

UTI Asset Management Company Ltd has declared a 240% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 240%<BR>- Amount per share: 24 <BR>- Ex-date: 18 Jul 24<BR><BR>Dividend Yield: 3.96%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -7.18%, with a dividend return of 0%, resulting in a total return of -7.18%.<BR><BR>Over the past year, the price return was 28.15%, the dividend return was 2.44%, leading to a total return of 30.59%.<BR><BR>In the 2-year period, the price return was 68.05%, with a dividend return of 6.70%, culminating in a total return of 74.75%.<BR><BR>For the 3-year period, the price return was 86.97%, the dividend return was 10.74%, resulting in a total return of 97.71%.<BR><BR>In the last 4 years, the price return was 61.73%, with a dividend return of 9.68%, leading to a total return of 71.41%.<BR><BR>Over the past 5 years, the price return was 0%, with a dividend return of 0%, resulting in a total return of 0.0%.<BR><BR>Overall, UTI AMC has declared a significant dividend, and the total returns over various periods indicate strong performance, particularly in the longer terms, despite a recent downturn in the short term.